跳至主要内容
临床试验/NCT05550662
NCT05550662终止2 期

Hyperpolarized 129Xe Magnetic Resonance Imaging for Evaluation of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2024年2月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
6
试验地点
2
主要终点
129Xe-MRI

研究概览

简要总结

To evaluate the feasibility of hyperpolarized 129Xe MRI in lung transplant recipients and assess structural and functional pulmonary changes using hyperpolarized 129Xe MRI

详细描述

Lung transplantation is an effective treatment for end-stage lung disease. However, median survival post-LTx is 6 years. This is primarily due to chronic lung allograft dysfunction (CLAD).

Clinical management of LTx recipients is focused on identifying early risk factors for CLAD, by monitoring graft function with spirometry and transbronchial biopsies. However, both have significant limitations.

Hyperpolarized (HP) noble gas lung MRI (3He and 129Xe) allows mapping of both lung anatomy and function. 129Xe-MRI could provide a diagnostic tool that is able to detect CLAD more sensitively and earlier than the current gold standard measurements of spirometry and plethysmography, and thus allow a means to detect and prevent /slow down irreparable and irreversible damage to the lungs in the early stages of disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients, deemed clinically stable by the lung transplant team at UHN Toronto Lung Transplant Program (TLTP), 18 years of age or older
  • Double lung transplant recipient
  • For the 5 CLAD-free participants - at least 1 year of follow-up post-LTx and no substantial and persistent FEV1 decline (as per the ISHLT CLAD definition).
  • For the 10 participants with CLAD - prior diagnosis of CLAD made by the clinical team (member of the TLTP).
  • PFT measurements within 1 month of scan visit.
  • FEV1 > 1.0 L

排除标准

  • Currently pregnant or lactating
  • Psychiatric or addictive disorders that would preclude obtaining informed consent or adherence to protocol
  • Inability to travel to obtain MRI scan
  • Any contraindications to MRI including but not limited to severe claustrophobia, implanted devices, aneurysm clips, neurostimulators (patients will be prescreened prior to registration).
  • Baseline oxygen saturation of less than 88%.
  • Requiring supplemental oxygen at baseline

研究组 & 干预措施

Single arm

Experimental

Participants will inhale hyperpolarized 129Xe gas.

干预措施: 129Xenon (Drug)

结局指标

主要结局

129Xe-MRI

时间窗: 1 year

Ventilation defect percent (VDP)

次要结局

  • 1H-MRI(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giles Santyr

Dr Giles Santyr (PhD)

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验

HP 129Xe MRI for Evaluation of CLAD in Lung... | 临床试验